• 1
    Hummel D, Loffler D, Fink G, Ternes TA. 2006. Simultaneous determination of psychoactive drugs and their metabolites in aqueous matrices by liquid chromatography mass spectrometry. Environ Sci Technol 40: 73217328.
  • 2
    Batt AL, Bruce IB, Aga DS. 2006. Evaluating the vulnerability of surface waters to antibiotic contamination from varying wastewater treatment plant discharges. Environ Pollut 142: 295302.
  • 3
    Glassmeyer ST, Furlong ET, Kolpin DW, Cahill JD, Zaugg SD, Werner SL, Meyer MT, Kryak DD. 2005. Transport of chemical and microbial compounds from known wastewater discharges: Potential for use as indicators of human fecal contamination. Environ Sci Technol 39: 51575169.
  • 4
    Ankley GT, Brooks BW, Huggett DB, Sumpter JP. 2007. Repeating history: Pharmaceuticals in the environment. Environ Sci Technol 41: 82118217.
  • 5
    Zhou SN, Oakes KD, Servos MR, Pawliszyn J. 2008. Application of solid-phase microextraction for in vivo laboratory and field sampling of pharmaceuticals in fish. Environ Sci Technol 42: 60736079.
  • 6
    Boxall ABA, Sinclair CJ, Fenner K, Kolpin D, Maund SJ. 2004. When synthetic chemicals degrade in the environment. Environ Sci Technol 38: 368A375A.
  • 7
    Filby AL, Neuparth T, Thorpe KL, Owen R, Galloway TS, Tyler CR. 2007. Health impacts of estrogens in the environment, considering complex mixture effects. Environ Health Perspect 115: 17041710.
  • 8
    Sumpter JP, Johnson AC. 2005. Lessons from endocrine disruption and their application to other issues concerning trace organics in the aquatic environment. Environ Sci Technol 39: 43214332.
  • 9
    Wilson BA, Smith VH, deNoyelles F, Larive CK. 2003. Effects of three pharmaceutical and personal care products on natural freshwater algal assemblages. Environ Sci Technol 37: 17131719.
  • 10
    Bedner M, MacCrehan WA. 2006. Transformation of acetaminophen by chlorination produces the toxicants 1,4-benzoquinone andN-acetyl-p-benzoquinone imine. Environ Sci Technol 40: 516522.
  • 11
    Hansen M, Krogh KA, Brandt A, Christensen JH, Halling-Sørensen B. 2009. Fate and antibacterial potency of anticoccidial drugs and their main abiotic degradation products. Environ Pollut 157: 474480.
  • 12
    Ardrey RE. 2003. Liquid Chromatography-Mass Spectrometry: An Introduction. John Wiley, West Sussex, UK.
  • 13
    Jones OAH, Voulvoulis N, Lester JN. 2001. Human pharmaceuticals in the aquatic environment. A review. Environ Technol 22: 13831394.
  • 14
    Khetan SK, Collins TJ. 2007. Human pharmaceuticals in the aquatic environment: A challenge to green chemistry. Chem Rev 107: 23192364.
  • 15
    Testa B, Jenner P. 1978. Novel drug metabolites produced by functionalization reactions: Chemistry and toxicology. Drug Metab Rev 7: 325369.
  • 16
    Danielson PB. 2002. The cytochrome P450 superfamily: Biochemistry, evolution and drug metabolism in humans. Curr Drug Metab 3: 561597.
  • 17
    Zhou S, Chan E, Duan W, Huang M, Chen Y-Z. 2005. Drug bioactivation, covalent binding to target proteins and toxicity relevance. Drug Metab Rev 37: 41213.
  • 18
    Shipkova M, Armstrong VW, Oellerich M, Wieland E. 2003. Acyl glucuronide drug metabolites: Toxicological and analytical implications. Ther Drug Monit 25: 116.
  • 19
    Ogilvie BW, Zhang D, Li W, Rodrigues AD, Gipson AE, Holsapple J, Toren P, Parkinson A. 2006. Glucuronidation converts gemfibrozil to a potent, metabolism-dependent inhibitor of CYP2C8: Implications for drug-drug interactions. Drug Metab Dispos 34: 191197.
  • 20
    Walgren JL, Mitchell MD, Thompson DC. 2005. Role of metabolism in drug-induced idiosyncratic hepatotoxicity. Crit Rev Toxicol 35: 325361.
  • 21
    Nałcz-Jawecki G. 2008. In vitro biotransformation of amitriptyline and imipramine with rat hepatic S9 fraction: Evaluation of the toxicity with Spirotox and Thamnotoxkit F™ tests. Arch Environ Contam Toxicol 54: 266273.
  • 22
    Vanderford BJ, Snyder SA. 2006. Analysis of pharmaceuticals in water by isotope dilution liquid chromatography/tandem mass spectrometry. Environ Sci Technol 40: 73127320.
  • 23
    Brooks BW, Chambliss CK, Stanley JK, Ramirez A, Banks KE, Johnson RD, Lewis RJ. 2005. Determination of select antide-pressants in fish from an effluent-dominated stream. Environ Toxicol Chem 24: 464469.
  • 24
    Nałcz-Jawecki G. 2007. Evaluation of the in vitro biotransformation of fluoxetine with HPLC, mass spectrometry and ecotoxicological tests. Chemosphere 70: 2935.
  • 25
    Mompelat S, LeBot B, Thomas O. 2009. Occurrence and fate of pharmaceutical products and by-products, from resource to drinking water. Environ Int 35: 803814.
  • 26
    Weigel S, Berger U, Jensen E, Kallenborn R, Thoresen H, Hühnerfuss H. 2004. Determination of selected pharmaceuticals and caffeine in sewage and seawater from Tromsø/Norway with emphasis on ibuprofen and its metabolites. Chemosphere 56: 583592.
  • 27
    Bendz D, Paxéus NA, Ginn TR, Loge FJ. 2005. Occurrence and fate of pharmaceutically active compounds in the environment, a case study: Höje River in Sweden. J Hazard Mater 122: 195204.
  • 28
    Reddersen K, Heberer T, Dünnbier U. 2002. Identification and significance of phenazone drugs and their metabolites in ground and drinking water. Chemosphere 49: 539544.
  • 29
    Zuehlke S, Duennbier U, Heberer T. 2007. Investigation of the behavior and metabolism of pharmaceutical residues during purification of contaminated ground water used for drinking water supply. Chemosphere 69: 16731680.
  • 30
    Fono LJ, Sedlak DL. 2005. Use of the chiral pharmaceutical propranolol to identify sewage discharges into surface waters. Environ Sci Technol 39: 92449252.
  • 31
    Nałcz-Jawecki G, Wojcik T, Sawicki J. 2008. Evaluation of in vitro biotransformation of propranolol with HPLC, MS/MS, and two bioassays. Environ Toxicol 23: 5258.
  • 32
    Talaat RE, Nelson WL. 1988. Regioisomeric aromatic dihydroxylation of propranolol. Use of monohydroxylated intermediates for structural assignments of the metabolites formed in vitro. Drug Metab Dispos 16: 207211.
  • 33
    Walle T, Walle UK, Olanoff LS. 1985. Quantitative account of propranolol metabolism in urine of normal man. Drug Metab Dispos 13: 204209.
  • 34
    Köhler A, Hellweg S, Escher BI, Hungerbuhler K. 2006. Organic pollutant removal versus toxicity reduction in industrial wastewater treatment: The example of wastewater from fluorescent whitening agent production. Environ Sci Technol 40: 33953401.
  • 35
    Zaugg S, Zhang X, Sweedler J, Thormann W. 2001. Determination of salicylate, gentisic acid and salicyluric acid in human urine by capillary electrophoresis with laser-induced fluorescence detection. J Chromatogr B 752: 1731.
  • 36
    Ternes TA. 1998. Occurrence of drugs in German sewage treatment plants and rivers. Water Res 32: 32453260.
  • 37
    Carrara C, Ptacek CJ, Robertson WD, Blowes DW, Moncur MC, Sverko E, Backus S. 2008. Fate of pharmaceutical and trace organic compounds in three septic system plumes, Ontario, Canada. Environ Sci Technol 42: 28052811.
  • 38
    Comeau F, Surette C, Brun GL, Losier R. 2008. The occurrence of acidic drugs and caffeine in sewage effluents and receiving waters from three coastal watersheds in Atlantic Canada. Sci Total Environ 396: 132146.
  • 39
    Gibson R, Becerril-Bravo E, Silva-Castro V, Jiménez B. 2007. Determination of acidic pharmaceuticals and potential endocrine disrupting compounds in wastewaters and spring waters by selective elution and analysis by gas chromatography-mass spectrometry. J Chromatogr A 1169: 3139.
  • 40
    Henschel KP, Wenzel A, Diedrich M, Fliedner A. 1997. Environmental hazard assessment of pharmaceuticals. Regul Toxicol Pharmacol 25: 220225.
  • 41
    Marques CR, Abrantes N, Goncalves F. 2004. Life-history traits of standard and autochthonous cladocerans: II. Acute and chronic effects of acetylsalicylic acid metabolites. Environ Toxicol 19: 527540.
  • 42
    Batt AL, Kostich MS, Lazorchak JM. 2008. Analysis of ecologically relevant pharmaceuticals in wastewater and surface water using selective solid-phase extraction and UPLC-MS/MS. Anal Chem 80: 50215030.
  • 43
    Ju C, Uetrecht JP. 1999. Detection of 2-hydroxyiminostilbene in the urine of patients taking carbamazepine and its oxidation to a reactive iminoquinone intermediate. J Pharmacol Exp Ther 288: 5156.
  • 44
    Furst SM, Sukhai P, McClelland RA, Uetrecht JP. 1995. Covalent binding of carbamazepine oxidative metabolites to neutrophils. Drug Metab Dispos 23: 590594.
  • 45
    Furst SM, Uetrecht JP. 1995. The effect of carbamazepine and its reactive metabolite, 9-acridine carboxaldehyde, on immune cell function in vitro. Int J Immunopharmacol 17: 445452.
  • 46
    Bennett GD, Amore BM, Finnell RH, Wlodarczyk B, Kalhorn TF, Skiles GL, Nelson SD, Slattery JT. 1996. Teratogenicity of carbamazepine-10,11-epoxide and oxcarbazepine in the SWV mouse. J Pharmacol Exp Ther 279: 12371242.
  • 47
    Zhao X, Metcalfe CD. 2008. Characterizing and compensating for matrix effects using atmospheric pressure chemical ionization liquid chromatographytandem mass spectrometry: Analysis of neutral pharmaceuticals in municipal wastewater. Anal Chem 80: 20102017.
  • 48
    Miao XS, Yang JJ, Metcalfe CD. 2005. Carbamazepine and its metabolites in wastewater and in biosolids in a municipal wastewater treatment plant. Environ Sci Technol 39: 74697475.
  • 49
    Miao XS, Metcalfe CD. 2003. Determination of carbamazepine and its metabolites in aqueous samples using liquid chromatography-electrospray tandem mass spectrometry. Anal Chem 75: 37313738.
  • 50
    Topp E, Monteiro SC, Beck A, Coelho BB, Boxall ABA, Duenk PW, Kleywegt S, Lapen DR, Payne M, Sabourin L, Li H, Metcalfe CD. 2008. Runoff of pharmaceuticals and personal care products following application of biosolids to an agricultural field. Sci Total Environ 396: 5259.
  • 51
    Batt AL, Snow DD, Aga DS. 2006. Occurrence of sulfonamide antimicrobials in private water wells in Washington County, Idaho, USA. Chemosphere 64: 19631971.
  • 52
    Gobel A, McArdell CS, Suter MJF, Giger W. 2004. Trace determination of macrolide and sulfonamide antimicrobials, a human sulfonamide metabolite, and trimethoprim in wastewater using liquid chromatography coupled to electrospray tandem mass spectrometry. Anal Chem 76: 47564764.
  • 53
    Gruchalla RS. 1999. Diagnosis of allergic reactions to sulfonamides. Allergy 54: 2832.
  • 54
    Ashton D, Hilton M, Thomas KV. 2004. Investigating the environmental transport of human pharmaceuticals to streams in the United Kingdom. Sci Total Environ 333: 167184.
  • 55
    Gobel A, Thomsen A, McArdell CS, Joss A, Giger W. 2005. Occurrence and sorption behavior of sulfonamides, macrolides, and trimethoprim in activated sludge treatment. Environ Sci Technol 39: 39813989.
  • 56
    Clement B, Behrens D, Amschler J, Matschke K, Wolf S, Havemeyer A. 2005. Reduction of sulfamethoxazole and dapsone hydroxylamines by a microsomal enzyme system purified from pig liver and pig and human liver microsomes. Life Sci 77: 205219.
  • 57
    Kasprzyk-Hordern B, Dinsdale RM, Guwy AJ. 2008. The effect of signal suppression and mobile phase composition on the simultaneous analysis of multiple classes of acidic/neutral pharmaceuticals and personal care products in surface water by solid-phase extraction and ultra performance liquid chromatography-negative electrospray tandem mass spectrometry. Talanta 74: 12991312.
  • 58
    Hargus SJ, Amouzedeh HR, Pumford NR, Myers TG, McCoy SC, Pohl LR. 1994. Metabolic activation and immunochemical localization of liver protein adducts of the nonsteroidal anti-inflammatory drug diclofenac. Chem Res Toxicol 7: 575582.
  • 59
    Shen S, Marchick MR, Davis MR, Doss GA, Pohl LR. 1999. Metabolic activation of diclofenac by human cytochrome P450 3A4: Role of 5-hydroxydiclofenac. Chem Res Toxicol 12: 214222.
  • 60
    Gröning J, Held C, Garten C, Claußnitzer U, Kaschabek SR, Schlömann M. 2007. Transformation of diclofenac by the indigenous microflora of river sediments and identification of a major intermediate. Chemosphere 69: 509516.
  • 61
    Deng A, Himmelsbach M, Zhu Q-Z, Frey S, Sengl M, Buchberger W, Niessner R, Knopp D. 2003. Residue analysis of the pharmaceutical diclofenac in different water types using ELISA and GC-MS. Environ Sci Technol 37: 34223429.
  • 62
    Arcand-Hoy LD, Nimrod AC, Benson WH. 1998. Endocrine-modulating substances in the environment: Estrogenic effects of pharmaceutical products. Int J Toxicol 17: 139158.
  • 63
    Pojana G, Bonfa A, Busetti F, Collarin A, Marcomini A. 2004. Determination of natural and synthetic estrogenic compounds in coastal lagoon waters by HPLC-electrospray-mass spectrometry. Int J Environ Anal Chem 84: 717727.
  • 64
    Routledge EJ, Sheahan D, Desbrow C, Brighty GC, Waldock M, Sumpter JP. 1998. Identification of estrogenic chemicals in STW effluent. 2. In vivo responses in trout and roach. Environ Sci Technol 32: 15591565.
  • 65
    Thorpe KL, Cummings RI, Hutchinson TH, Scholze M, Brighty G, Sumpter JP, Tyler CR. 2003. Relative potencies and combination effects of steroidal estrogens in fish. Environ Sci Technol 37: 11421149.
  • 66
    Caldwell DJ, Mastrocco F, Hutchinson TH, Lange R, Heijerick D, Janssen C, Anderson PD, Sumpter JP. 2008. Derivation of an aquatic predicted no-effect concentration for the synthetic hormone, 17α-ethinyl estradiol. Environ Sci Technol 42: 70467054.
  • 67
    Reddy S, Iden CR, Brownawell BJ. 2005. Analysis of steroid conjugates in sewage influent and effluent by liquid chromatography-tandem mass spectrometry. Anal Chem 77: 70327038.
  • 68
    Ternes TA, Kreckel P, Mueller J. 1999. Behaviour and occurrence of estrogens in municipal sewage treatment plants—II. Aerobic batch experiments with activated sludge. Sci Total Environ 225: 9199.
  • 69
    Matejicek D, Houserova P, Kuban V. 2007. Combined isolation and purification procedures prior to the high-performance liquid chromatographic-ion-trap tandem mass spectrometric determination of estrogens and their conjugates in river sediments. J Chromatogr A 1171: 8089.
  • 70
    D'Ascenzo G, Di Corcia A, Gentili A, Mancini R, Mastropasqua R, Nazzari M, Samperi R. 2003. Fate of natural estrogen conjugates in municipal sewage transport and treatment facilities. Sci Total Environ 302: 199209.
  • 71
    Skotnicka-Pitak J, Khunjar WO, Love NG, Aga DS. 2009. Characterization of metabolites formed during the biotransformation of 17α-ethinylestradiol by Nitrosomonas europaea in batch and continuous flow bioreactors. Environ Sci Technol 43: 35493555.
  • 72
    Kosjek T, Heath E, Petrovic M, Barcelo D. 2007. Mass spectrometry for identifying pharmaceutical biotransformation products in the environment. Trends Anal Chem 26: 10761085.
  • 73
    Eichhorn P, Aga DS. 2004. Identification of a photooxygenation product of chlortetracycline in hog lagoons using LC/ESI-ion trap-MS and LC/ESI-time-of-flight-MS. Anal Chem 76: 60026011.
  • 74
    Eichhorn P, Ferguson PL, Perez S, Aga DS. 2005. Application of ion trap-MS with H/D exchange and QqTOF-MS in the identification of microbial degradates of trimethoprim in nitrifying activated sludge. Anal Chem 77: 41764184.
  • 75
    Perez S, Eichhorn P, Celiz MD, Aga DS. 2006. Structural characterization of metabolites of the X-ray contrast agent iopromide in activated sludge using ion trap mass spectrometry. Anal Chem 78: 18661874.
  • 76
    Ma S, Chowdhury SK, Alton KB. 2006. Application of mass spectrometry for metabolite identification. Curr Drug Metab 7: 503523.
  • 77
    Schulz M, Löffler D, Wagner M, Ternes TA. 2008. Transformation of the X-ray contrast medium iopromide in soil and biological wastewater treatment. Environ Sci Technol 42: 72077217.
  • 78
    Wolfender J-L, Ndjoko K, Hostettmann K. 2001. The potential of LC-NMR in phytochemical analysis. Phytochem Anal 12: 222.
  • 79
    Wilson ID. 2000. Multiple hyphenation of liquid chromatography with nuclear magnetic resonance spectroscopy, mass spectrometry and beyond. J Chromatogr A 892: 315327.
  • 80
    Corcoran O, Spraul M. 2003. LC-NMR-MS in drug discovery. Drug Discov Today 8: 624631.
  • 81
    Godejohann M, Tseng L-H, Braumann U, Fuchser J, Spraul M. 2004. Characterization of a paracetamol metabolite using on-line LC-SPE-NMR-MS and a cryogenic NMR probe. J Chromatogr A 1058: 191196.
  • 82
    Sandvoss M, Roberts AD, Ismail IM, North SE. 2004. Direct online hyphenation of capillary liquid chromatography to nuclear magnetic resonance spectroscopy: Practical aspects and application to drug metabolite identification. J Chromatogr A 1028: 259266.
  • 83
    Albert K. 1999. Liquid chromatography-nuclear magnetic resonance spectroscopy. J Chromatogr A 856: 199211.
  • 84
    Yang Z. 2006. Online hyphenated liquid chromatography-nuclear magnetic resonance spectroscopy-mass spectrometry for drug metabolite and nature product analysis. J Pharm Biomed Anal 40: 516527.
  • 85
    Exarchou V, Krucker M, Beek TAV, Vervoort J, Gerothanassis IP, Albert K. 2005. LC-NMR coupling technology: Recent advancements and applications in natural products analysis. Magn Reson Chem 43: 681687.
  • 86
    Hernando MD, Mezcua M, Gomez MJ, Malato O, Agueera A, Fernandez-Alba AR. 2004. Comparative study of analytical methods involving gas chromatography-mass spectrometry after derivatization and gas chromatography-tandem mass spectrometry for the determination of selected endocrine disrupting compounds in wastewaters. J Chromatogr A 1047: 129135.
  • 87
    Kosjek T, Heath E, Kompare B. 2007. Removal of pharmaceutical residues in a pilot wastewater treatment plant. Anal Bioanal Chem 387: 13791387.
  • 88
    Reddersen K, Heberer T. 2003. Multi-compound methods for the detection of pharmaceutical residues in various waters applying solid phase extraction (SPE) and gas chromatography with mass spectrometric (GC-MS) detection. J Sep Sci 26: 14431450.
  • 89
    Meng L-J, Sjovall J. 1997. Method for combined analysis of profiles of conjugated progesterone metabolites and bile acids in serum and urine of pregnant women. J Chromatogr B 688: 1126.
  • 90
    Mouatassim-Souali A, Tamisier-Karolak SL, Perdiz D, Cargouet M, Levi Y. 2003. Validation of a quantitative assay using GC/MS for trace determination of free and conjugated estrogens in environmental water samples. J Sep Sci 26: 105111.
  • 91
    Labadie P, Budzinski H. 2005. Determination of steroidal hormone profiles along the Jalle d'Eysines River (near Bordeaux, France). Environ Sci Technol 39: 51135120.
  • 92
    Eggen RIL, Behra R, Burkhardt-Holm P, Escher BI, Schweigert N. 2004. Challenges in ecotoxicology. Environ Sci Technol 38: 58A64A.
  • 93
    Harder A, Escher BI, Schwarzenbach RP. 2003. Applicability and limitation of QSARs for the toxicity of electrophilic chemicals. Environ Sci Technol 37: 49554961.
  • 94
    Sanderson H, Thomsen M. 2009. Comparative analysis of pharmaceuticals versus industrial chemicals acute aquatic toxicity classification according to the United Nations classification system for chemicals. Assessment of the (Q)SAR predictability of pharmaceuticals acute aquatic toxicity and their predominant acute toxic mode-of-action. Toxicol Lett 187: 8493.
  • 95
    Gutiérrez S, Fernández C, Escher BI, Tarazona JV. 2008. A new hazard index of complex mixtures integrates bioconcentration and toxicity to refine the environmental risk assessment of effluents. Environ Int 34: 773781.
  • 96
    Escher BI, Bramaz N, Eggen RIL, Richter M. 2005. In vitro assessment of modes of toxic action of pharmaceuticals in aquatic life. Environ Sci Technol 39: 30903100.
  • 97
    Dix DJ, Houck KA, Martin MT, Richard AM, Setzer RW, Kavlock RJ. 2007. The ToxCast program for prioritizing toxicity testing of environmental chemicals. Toxicol Sci 95: 512.
  • 98
    Lienert J, Gudel K, Escher BI. 2007. Screening method for ecotoxicological hazard assessment of 42 pharmaceuticals considering human metabolism and excretory routes. Environ Sci Technol 41: 44714478.
  • 99
    Houtman CJ, van Houten YK, Leonards PEG, Brouwer A, Lamoree MH, Legler J. 2006. Biological validation of a sample preparation method for ER-CALUX bioanalysis of estrogenic activity in sediment using mixtures of xeno-estrogens. Environ Sci Technol 40: 24552461.
  • 100
    Van Liempd SM, Kool J, Meerman JH, Irth H, Vermeulen NP. 2007. Metabolic profiling of endocrine-disrupting compounds by on-line cytochrome P450 bioreaction coupled to on-line receptor affinity screening. Chem Res Toxicol 20: 18251832.
  • 101
    Pomati F, Orlandi C, Clerici M, Luciani F, Zuccato E. 2008. Effects and interactions in an environmentally relevant mixture of pharmaceuticals. Toxicol Sci 102: 129137.
  • 102
    Morley NJ. 2009. Environmental risk and toxicology of human and veterinary waste pharmaceutical exposure to wild aquatic host-parasite relationships. Environ Toxicol Pharmacol 27: 161175.
  • 103
    Besse J-P, Kausch-Barreto C, Garric J. 2008. Exposure assessment of pharmaceuticals and their metabolites in the aquatic environment: Application to the French situation and preliminary prioritization. Human Ecol Risk Assess 14: 665695.
  • 104
    Grung M, Kaellqvist T, Sakshaug S, Skurtveit S, Thomas KV. 2008. Environmental assessment of Norwegian priority pharmaceuticals based on the EMEA guideline. Ecotoxicol Environ Saf 71: 328340.
  • 105
    Cunningham VL, Binks SP, Olson MJ. 2009. Human health risk assessment from the presence of human pharmaceuticals in the aquatic environment. Regul Toxicol Pharmacol 53: 3945.
  • 106
    Christensen FM. 1998. Pharmaceuticals in the environment—A human risk?. Regul Toxicol Pharmacol 28: 212221.